ISOL
ISOL

Isodiol International Inc.

Status
Delisted
Issued & Outstanding128,534,359
Reserved for Issuance2,607,754
Currency
CSE Index

About

Isodiol International Inc.

Listing date
July 08, 2014

Isodiol International Inc. ("Isodiol"), focused on the nutritional health benefits  derived from hemp, is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions.

Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products. Isodiol has received approval for its CBD designated as an Active Pharmaceutical Ingredient for use in Finished Pharmaceutical Products. 

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its consumer products portfolio and aggressively continue international expansion into Latin America, Asia, and Europe.